Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates
Top Cited Papers
- 10 October 2005
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 46,p. 5739-5741
- https://doi.org/10.1039/b507350b
Abstract
PAMAM dendrimer–RGD-4C peptide conjugate was synthesized and in vitro targeting efficacy to integrin receptor expressing cells was studied by flow cytometry and confocal microscopy.Keywords
This publication has 13 references indexed in Scilit:
- Targeting tumor angiogenic vasculature using polymer–RGD conjugatesJournal of Controlled Release, 2005
- Endothelial signaling during developmentNature Medicine, 2003
- Integrin targeting using RGD‐PEI conjugates for in vitro gene transferThe Journal of Gene Medicine, 2003
- Dendritic polymer macromolecular carriers for drug deliveryCurrent Opinion in Chemical Biology, 2002
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancerSeminars in Oncology, 2001
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Tumour vasculature - a potential therapeutic targetBritish Journal of Cancer, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994